Dynamic pH fluctuations in cancer cells on CMOS-based Lab-on-Chip ISFET arrays
Early diagnosis of cancer is a key avenue to improving cancer incidence rates and prognosis. This paper presents a rapid assay for live, mammalian cancer cell culture on a Lab-on-Chip ISFET array fabricated in CMOS technology. Detection of osteosarcoma cells is recorded as a significant difference in endpoint $\mathbf{p H}$ on ISFET sensors. Control measurements of $\mathbf{p H}$ change in cell culture media due to any CO<inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</inf> supply fluctuations in an incubator allow compensation of non-ideal effects including sensor drift and baseline $\mathbf{p H}$ change associated with a bicarbonate buffering system. Distinguishing metrics, including total drift rate and standard deviation of sensor output are extracted and attributed to cell presence on-chip. Mean total drift rate shows an 89.7% difference between sample and control wells, aiding characterisation of cancer cell presence. Standard deviation captures the noise output attributed to cell culture on the sensor surface, reporting an $\mathbf{8 1. 4 \%}$ difference between populations. This Point-of-Care diagnostic device and assay for rapid cell detection on a Lab-on-Chip shows significant potential to provide a rapid and cost-effective diagnostic tool for live cell measurements.
Authors
- Vicky Bousgouni
- Chris Bakal (ORCID: https://orcid.org/0000-0002-0413-6744)
- Nicolas Moser (ORCID: https://orcid.org/0000-0002-6689-0486)
- Pantelis Georgiou (ORCID: https://orcid.org/0000-0003-2476-3857)
- Melina Beykou (ORCID: https://orcid.org/0000-0002-2155-1384)
- Costanza Gulli (ORCID: https://orcid.org/0000-0001-6140-5667)
Institutions
- Institute of Cancer Research (GB)
- Imperial College London (GB)
Publication Details
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1109/biocas61083.2024.10798162
- Primary Topic
- Analytical Chemistry and Sensors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Imperial College London
- Institute of Cancer Research